Literature DB >> 12183246

High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.

Lee-Jene Teng1, Po-Ren Hsueh, Jui-Chang Tsai, Shwu-Jen Liaw, Shen-Wu Ho, Kwen-Tay Luh.   

Abstract

Susceptibilities to 16 antimicrobial agents were determined by measurement of MICs for 344 isolates of anaerobic bacteria recovered from patients with significant infections. Resistance rates varied among antimicrobial agents and the species tested. The beta-lactams were more active in gram-positive than in gram-negative anaerobes. Resistance to meropenem was low (<1%). For beta-lactam-beta-lactamase inhibitors, piperacillin-tazobactam was most active for all species (resistance, <6%). The rates of resistance to cefoxitin (31 to 65%) and clindamycin (50 to 70%) for non-Bacteroides fragilis species of the B. fragilis group were higher than those for B. fragilis (4% resistant to cefoxitin and 33% resistant to clindamycin). Among members of B. fragilis group, Bacteroides thetaiotaomicron was the most resistant to clindamycin (70%) and cefoxitin (65%). Rates of susceptibility to imipenem and metronidazole for B. fragilis continue to be high compared to those from a previous study 10 years ago. However, resistance to metronidazole was found recently in five strains of B. fragilis. We analyzed the genetic relationships among the metronidazole-resistant B. fragilis strains by pulsed-field gel electrophoresis. The metronidazole-resistant B. fragilis strains showed genotypic heterogeneity, excluding the dissemination of a single clone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183246      PMCID: PMC127412          DOI: 10.1128/AAC.46.9.2908-2913.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.

Authors:  A C Labbé; A M Bourgault; J Vincelette; P L Turgeon; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis.

Authors:  L J Teng; S W Ho; S C Chang; K T Luh; W C Hsieh
Journal:  J Formos Med Assoc       Date:  1991-08       Impact factor: 3.282

3.  PCR assay for species-specific identification of Bacteroides thetaiotaomicron.

Authors:  L J Teng; P R Hsueh; J C Tsai; F L Chiang; C Y Chen; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.

Authors:  M D Appleman; P N Heseltine; C E Cherubin
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

7.  Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.

Authors:  K Lee; Y Chong; S H Jeong; X S Xu; O H Kwon
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

8.  Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

Authors:  D R Snydman; L McDermott; G J Cuchural; D W Hecht; P B Iannini; L J Harrell; S G Jenkins; J P O'Keefe; C L Pierson; J D Rihs; V L Yu; S M Finegold; S L Gorbach
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

9.  Attributable mortality of bacteremia associated with the Bacteroides fragilis group.

Authors:  M C Redondo; M D Arbo; J Grindlinger; D R Snydman
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

10.  DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis.

Authors:  H Böhm; H Karch
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  18 in total

1.  Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.

Authors:  Anastasia Katsandri; Joseph Papaparaskevas; Angeliki Pantazatou; Georgios L Petrikkos; Georgios Thomopoulos; Dimitra P Houhoula; Athina Avlamis
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Authors:  Carmen Betriu; Esther Culebras; María Gómez; Fátima López; Iciar Rodríguez-Avial; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

3.  In vitro activity of ten antibiotics, including tigecycline, against Bacteroides species in Austria.

Authors:  A J Grisold; I Wendelin; E Presterl; R B Raggam; L Masoud; A Badura; E Marth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 3.267

4.  Identification of clinically important anaerobic bacteria by an oligonucleotide array.

Authors:  Yu Tzu Lin; Mario Vaneechoutte; Ay Huey Huang; Lee Jene Teng; Hung-Mo Chen; Shu-Li Su; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

5.  Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?

Authors:  Nurver Ulger Toprak; Bahadir M Güllüoğlu; Ozlem Cakici; M Levhi Akin; Pakize Demirkalem; Tuncay Celenk; Güner Söyletir
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

6.  Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.

Authors:  M N Austin; R H Beigi; L A Meyn; S L Hillier
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 7.  Polymicrobial endocarditis involving Veillonella parvula in an intravenous drug user: case report and literature review of Veillonella endocarditis.

Authors:  M A Pérez-Jacoiste Asín; M Fernández-Ruiz; I Serrano-Navarro; S Prieto-Rodriguez; J M Aguado
Journal:  Infection       Date:  2013-03-01       Impact factor: 3.553

8.  Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008-2012, northern Taiwan.

Authors:  F D Wang; C H Liao; Y T Lin; W H Sheng; P R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

9.  Identification of Bacteroides thetaiotaomicron on the basis of an unexpected specific amplicon of universal 16S ribosomal DNA PCR.

Authors:  Lee-Jene Teng; Po-Ren Hsueh; Yu-Hsuan Huang; Jui-Chang Tsai
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Li-Ching Yen; Hsiu-Ying Lin; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.